| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 150, 409-415, Copyright © 1997 by American Society for Investigative Pathology
REGULAR ARTICLES |
S Walenta, A Salameh, H Lyng, JF Evensen, M Mitze, EK Rofstad and W Mueller- Klieser
Institute of Physiology and Pathophysiology, University of Mainz, Germany.
Using quantitative bioluminescence imaging, tissue concentrations of ATP, glucose, and lactate were registered in biopsies that were taken from primary tumors of human head and neck at the time of first cancer diagnosis. From 15 patients investigated at present, 6 had locoregional lymph node metastasis, 6 had no detectable metastatic spread, 2 biopsies contained dysplasias, and 1 biopsy consisted exclusively of normal mucosal and submucosal tissue. There was no correlation between staging or grading and any of the metabolic parameters measured. Mean lactate concentrations (+/-SD) were significantly higher and scattered over a wider range in tumors with metastatic spread (12.3 +/- 3.3 mumol/g) in comparison with malignancies in patients without metastasis (4.7 +/- 1.5 mumol/g). Despite the low number of patients, these differences were statistically highly significant (P < 0.005; Mann- Whitney). Neither ATP nor glucose contents showed such a correlation with the emergence of metastasis. Mean lactate contents of the two dysplasias were 0.1 and 3.5 mumol/g; that of the normal tissue was 0.1 mumol/g. Although these findings have to be verified in a higher number of patients, the present data indicate that elevated lactate levels in primary tumors of head and neck may be associated with a high risk of metastatic spread. With the underlying mechanisms remaining to the investigated, lactate imaging is possibly useful as an early indicator of the malignant potential of tumors in patients.
This article has been cited by other articles:
![]() |
H. Shime, M. Yabu, T. Akazawa, K. Kodama, M. Matsumoto, T. Seya, and N. Inoue Tumor-Secreted Lactic Acid Promotes IL-23/IL-17 Proinflammatory Pathway J. Immunol., June 1, 2008; 180(11): 7175 - 7183. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Fischer, P. Hoffmann, S. Voelkl, N. Meidenbauer, J. Ammer, M. Edinger, E. Gottfried, S. Schwarz, G. Rothe, S. Hoves, et al. Inhibitory effect of tumor cell-derived lactic acid on human T cells Blood, May 1, 2007; 109(9): 3812 - 3819. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Fang, Q. J. Quinones, T. L. Holman, M. J. Morowitz, Q. Wang, H. Zhao, F. Sivo, J. M. Maris, and M. L. Wahl The H+-Linked Monocarboxylate Transporter (MCT1/SLC16A1): A Potential Therapeutic Target for High-Risk Neuroblastoma Mol. Pharmacol., December 1, 2006; 70(6): 2108 - 2115. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. K. Rofstad, B. Mathiesen, K. Kindem, and K. Galappathi Acidic Extracellular pH Promotes Experimental Metastasis of Human Melanoma Cells in Athymic Nude Mice. Cancer Res., July 1, 2006; 66(13): 6699 - 6707. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Kwon and Y. J. Lee Effect of Low Glutamine/Glucose on Hypoxia-Induced Elevation of Hypoxia-Inducible Factor-1{alpha} in Human Pancreatic Cancer MiaPaCa-2 and Human Prostatic Cancer DU-145 Cells Clin. Cancer Res., July 1, 2005; 11(13): 4694 - 4700. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Li, D. B. Vigneron, S. Cha, E. E. Graves, F. Crawford, S. M. Chang, and S. J. Nelson Relationship of MR-Derived Lactate, Mobile Lipids, and Relative Blood Volume for Gliomas in Vivo AJNR Am. J. Neuroradiol., April 1, 2005; 26(4): 760 - 769. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Guo, K. Higashi, H. Yokota, Y. Nagao, Y. Ueda, Y. Kodama, M. Oguchi, S. Taki, H. Tonami, and I. Yamamoto In Vitro Proton Magnetic Resonance Spectroscopic Lactate and Choline Measurements, 18F-FDG Uptake, and Prognosis in Patients with Lung Adenocarcinoma J. Nucl. Med., August 1, 2004; 45(8): 1334 - 1339. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Wahl, T. L. Moser, and S. V. Pizzo Angiostatin and Anti-angiogenic Therapy in Human Disease Recent Prog. Horm. Res., January 1, 2004; 59(1): 73 - 104. [Abstract] [Full Text] |
||||
![]() |
T. Atsumi, J. Chesney, C. Metz, L. Leng, S. Donnelly, Z. Makita, R. Mitchell, and R. Bucala High Expression of Inducible 6-Phosphofructo-2-Kinase/Fructose-2,6-Bisphosphatase (iPFK-2; PFKFB3) in Human Cancers Cancer Res., October 15, 2002; 62(20): 5881 - 5887. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Rivenzon-Segal, R. Margalit, and H. Degani Glycolysis as a metabolic marker in orthotopic breast cancer, monitored by in vivo 13C MRS Am J Physiol Endocrinol Metab, October 1, 2002; 283(4): E623 - E630. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Lu, R. A. Forbes, and A. Verma Hypoxia-inducible Factor 1 Activation by Aerobic Glycolysis Implicates the Warburg Effect in Carcinogenesis J. Biol. Chem., June 21, 2002; 277(26): 23111 - 23115. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Helmlinger, A. Sckell, M. Dellian, N. S. Forbes, and R. K. Jain Acid Production in Glycolysis-impaired Tumors Provides New Insights into Tumor Metabolism Clin. Cancer Res., April 1, 2002; 8(4): 1284 - 1291. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Cairns, T. Kalliomaki, and R. P. Hill Acute (Cyclic) Hypoxia Enhances Spontaneous Metastasis of KHT Murine Tumors Cancer Res., December 1, 2001; 61(24): 8903 - 8908. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Crowther, N. J. Brown, E. T. Bishop, and C. E. Lewis Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors J. Leukoc. Biol., October 1, 2001; 70(4): 478 - 490. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Walenta, J. Doetsch, W. MuellerKlieser, and L. A. KunzSchughart Metabolic Imaging in Multicellular Spheroids of Oncogene-transfected Fibroblasts J. Histochem. Cytochem., April 1, 2000; 48(4): 509 - 522. [Abstract] [Full Text] |
||||
![]() |
S. Walenta, M. Wetterling, M. Lehrke, G. Schwickert, K. Sundfør, E. K. Rofstad, and W. Mueller-Klieser High Lactate Levels Predict Likelihood of Metastases, Tumor Recurrence, and Restricted Patient Survival in Human Cervical Cancers Cancer Res., February 1, 2000; 60(4): 916 - 921. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |